A deep learning model that fuses MRI scans and methylation array data to improve tumor subclass diagnosis, surface clinically meaningful imaging features, and generalize across diverse clinical datasets.
At the inaugural UCL Computational Cancer Collaboratorium Hackathon in December 2024, I contributed to a team project bridging computational science and cancer research. We developed a deep learning pipeline to enhance tumor diagnosis and classification by combining two complementary data modalities: structural information from MRI scans and molecular signals from methylation array data.
The goal was to move beyond single-modality models and build a system that could both classify tumor subclasses with greater accuracy and explain which imaging patterns drive those predictions — giving clinicians richer insight into how different tumor types present on scan.
Tumor subclassification is critical for prognosis and treatment planning, but diagnosis often relies on fragmented evidence across imaging and molecular assays. MRI captures spatial and morphological features, while methylation profiles encode epigenetic patterns linked to tumor biology. Without integrated models, valuable cross-modal signals can be missed, and models trained on one hospital's imaging protocol often fail when applied elsewhere due to inconsistent preprocessing and scanner variability.
The project demonstrated that combining MRI and methylation data can strengthen subclass prediction while surfacing imaging features clinicians can relate to. The normalization tooling was a practical step toward deployment — addressing one of the main barriers to translating research models into settings with heterogeneous scan protocols.
The hackathon reinforced how multidisciplinary collaboration — pairing computational methods with domain expertise in neuroradiology and cancer biology — accelerates progress on problems that neither imaging nor genomics alone can fully resolve.